Sun Pharma gets partial relief from US court in litigation involving three generic drugs

Drug major Sun Pharma is a defendant in a multi-district litigation brought by various classes of plaintiffs in the US District Court (District of Massachusetts), alleging a delay in the market entry for three generic drugs -- Valganciclovir, Valsartan and Esomeprazole. The company said it would continue to vigorously defend against all claims.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2sBZoZv
via IFTTT